Caredx Inc’s recent filing unveils that its Director GEORGE W BICKERSTAFF acquired Company’s shares for reported $0.37 million on Mar 10 ’25. In the deal valued at $18.36 per share,20,000 shares were bought.
Then, Novack Jeffrey Adam sold 3,512 shares, generating $81,829 in total proceeds. Upon selling the shares at $23.30, the Secretary and General Counsel now owns 104,677 shares.
Before that, Jeffrey Adam Novack bought 3,512 shares. Caredx Inc shares valued at $81,900 were divested by the Officer at a price of $23.32 per share.
Wells Fargo upgraded its Caredx Inc [CDNA] rating to an Equal weight from a an Underweight in a research note published on January 15, 2025; the price target was decreased to $24 from $28. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in late August with a ‘”an Underweight”‘ rating. BTIG Research also remained covering CDNA and has increased its forecast on August 19, 2024 with a “Buy” recommendation from previously “Neutral” rating. Raymond James revised its rating on May 13, 2024. It rated CDNA as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of CDNA
On Tuesday, Caredx Inc [NASDAQ:CDNA] saw its stock jump 1.71% to $18.40. Over the last five days, the stock has lost -9.36%. Caredx Inc shares have fallen nearly -14.06% since the year began. Nevertheless, the stocks have risen 54.10% over the past one year. While a 52-week high of $34.84 was reached on 01/14/25, a 52-week low of $7.42 was recorded on 03/11/25. SMA at 50 days reached $22.31, while 200 days put it at $22.79.
Levels Of Support And Resistance For CDNA Stock
The 24-hour chart illustrates a support level at 17.82, which if violated will result in even more drops to 17.25. On the upside, there is a resistance level at 18.88. A further resistance level may holdings at 19.36. The Relative Strength Index (RSI) on the 14-day chart is 33.18, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.13, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 90.13%. Stochastics %K at 7.07% indicates the stock is a buying.
